ECOR insider trading
NasdaqCM HealthcareelectroCore, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About electroCore, Inc.
electroCore, Inc., a bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an, app-enabled general wellness product. It also offers non-invasive bioelectronic therapies for the treatment of chronic pain and wellness conditions. In addition, the company offers TAC-STIM for human performance and gammaCore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Company website: www.electrocore.com
ECOR insider activity at a glance
FilingIQ has scored 137 insider transactions for ECOR since Jun 21, 2018. The most recent filing in our index is dated Apr 13, 2026.
Across the full history, 68 open-market purchases
and 10 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on ECOR insider trades is 57.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest ECOR Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for ECOR?
- FilingIQ tracks 137 Form 4 insider transactions for ECOR (electroCore, Inc.), covering filings from Jun 21, 2018 onwards. 7 of those were filed in the last 90 days.
- Are ECOR insiders net buyers or net sellers?
- Across the full Form 4 history for ECOR, 68 transactions (50%) were open-market purchases and 10 (7%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does ECOR insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is ECOR in?
- electroCore, Inc. (ECOR) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $52.41M.
Methodology & sources
Every ECOR insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.